ECM
DGX icon

Endex Capital Management’s Quest Diagnostics DGX Stock Holding History

Endex Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$84K Hold
1,561
– – 0.08% 256
2013
Q3 		$96K Hold
1,561
– – 0.1% 230
2013
Q2 		$95K Buy
+1,561
New +$93K 0.1% 227

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Endex Capital Management's DGX Position: Q4 2013 in Review

Endex Capital Management held its Quest Diagnostics (DGX) position steady in Q4 2013 at 1,561 shares worth $84K. The position accounts for 0.08% of the portfolio, ranked #256.

Endex Capital Management first reported a position in DGX in Q2 2013 and has held it in 3 quarters since. The position peaked at $96K in Q3 2013. 455 funds tracked by Wall St. Rank hold DGX as of Q4 2013.

  • Endex Capital Management held 1,561 shares of Quest Diagnostics worth $84K as of Q4 2013.
  • Endex Capital Management left its Quest Diagnostics share count unchanged in Q4 2013.
  • Quest Diagnostics made up 0.08% of Endex Capital Management's portfolio in Q4 2013, its #256 holding.
  • Endex Capital Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 3 quarters since.
  • Endex Capital Management's Quest Diagnostics position peaked at $96K in Q3 2013.
  • 455 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2013.

Based on Endex Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.